Commonwealth Retirement Investments LLC lifted its position in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 103.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,960 shares of the insurance provider’s stock after acquiring an additional 6,590 shares during the quarter. Commonwealth Retirement Investments LLC’s holdings in Allstate were worth $2,609,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Arlington Trust Co LLC increased its stake in shares of Allstate by 261.8% during the second quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 89 shares during the period. Hughes Financial Services LLC acquired a new position in shares of Allstate during the first quarter worth about $28,000. Caitong International Asset Management Co. Ltd increased its stake in shares of Allstate by 315.0% during the second quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock worth $33,000 after acquiring an additional 126 shares during the period. Hilltop National Bank acquired a new position in shares of Allstate during the second quarter worth about $34,000. Finally, Chilton Capital Management LLC acquired a new position in shares of Allstate during the second quarter worth about $38,000. 76.47% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms recently commented on ALL. Citigroup raised shares of Allstate to a “hold” rating in a report on Wednesday, August 13th. BMO Capital Markets boosted their price objective on shares of Allstate from $230.00 to $235.00 and gave the stock an “outperform” rating in a report on Wednesday, August 20th. Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a report on Wednesday, October 8th. Morgan Stanley boosted their price objective on shares of Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a report on Friday, August 1st. Finally, Roth Capital set a $230.00 price target on Allstate and gave the company a “buy” rating in a research report on Friday, September 26th. Two research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $234.27.
Allstate Stock Up 2.1%
ALL stock opened at $195.30 on Wednesday. The company’s 50 day simple moving average is $202.19 and its 200-day simple moving average is $201.10. The firm has a market capitalization of $51.46 billion, a PE ratio of 9.18, a P/E/G ratio of 0.69 and a beta of 0.38. The Allstate Corporation has a 12 month low of $176.00 and a 12 month high of $215.70. The company has a debt-to-equity ratio of 0.37, a current ratio of 0.43 and a quick ratio of 0.43.
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- Best Aerospace Stocks Investing
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Uber Is Crushing Lyft—And It’s Not Even Close
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
